BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9251603)

  • 21. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

  • 22. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borderline tuberculoid leprosy--an unusual presentation: a case report.
    Barman KD; Garg VK; Sahoo B; Caroli S
    Indian J Lepr; 2008; 80(1):7-9. PubMed ID: 19295116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facial reversal reaction: a dermatological emergency.
    Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract]   [Full Text] [Related]  

  • 26. Dapsone induced eosinophilic pneumonia.
    Adar T; Tayer-Shifman O; Mizrahi M; Tavdi S; Barak O; Shalit M
    Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):144-6. PubMed ID: 22905598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
    Al-Raqum HA; Uppal SS; El Abdalghani RA; Lasheen I
    Clin Rheumatol; 2006 Feb; 25(1):101-5. PubMed ID: 16247582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of lips and gums in a borderline tuberculoid leprosy patient.
    Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya GN; Girdhar BK
    Indian J Lepr; 1996; 68(4):367-70. PubMed ID: 9001905
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
    Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
    Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Problems and opportunities in the therapy of leprosy.
    Jopling WH
    Lepr Rev; 1974 Dec; 45(4):285-7. PubMed ID: 4444391
    [No Abstract]   [Full Text] [Related]  

  • 32. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 33. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polyarthritis and papular eruption revealing leprosy].
    Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
    Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V; al-Suwaid AR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract]   [Full Text] [Related]  

  • 36. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
    Andrade VL; Marques AB; da Cunha LH; Avelleira JR
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of life-threatening thrombocytopaenia in a patient on MDT and prednisolone.
    Croft R
    Lepr Rev; 1996 Sep; 67(3):229. PubMed ID: 8885619
    [No Abstract]   [Full Text] [Related]  

  • 38. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
    Ozturk Z; Tatliparmak A
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hansen's disease mimicking palmoplantar keratoderma.
    Agrawal US; Saxena A; Meena RS; Saini M; Saxena V
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):210-2. PubMed ID: 12483971
    [No Abstract]   [Full Text] [Related]  

  • 40. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.